NCT03609008View on ClinicalTrials.gov

The Effect of Levcromakalim Infusion on the Cranial Arteries Over Several Hours Using a High Resolution MRA Technique in a Randomized, Double-blind Placebo-controlled Design in Healthy Volunteers.

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 26, 2018

Primary Completion Date

August 15, 2018

Study Completion Date

August 15, 2018

Conditions
Dilatation of Cranial Arteries; MMA, STA and MCAHeadache
Interventions
DRUG

Levcromakalim

Intravenous administration of levcromakalim or placebo for 20 minutes. To investigate the role of levcromakalim/placebo on cerebral hemodynamic in healthy volunteers.

DRUG

Saline

Intravenous administration of levcromakalim or placebo for 20 minutes. To investigate the role of levcromakalim/placebo on cerebral hemodynamic in healthy volunteers.

Trial Locations (1)

2600

Danish headache center, Copenhagen

All Listed Sponsors
lead

Danish Headache Center

OTHER

NCT03609008 - The Effect of Levcromakalim Infusion on the Cranial Arteries Over Several Hours Using a High Resolution MRA Technique in a Randomized, Double-blind Placebo-controlled Design in Healthy Volunteers. | Biotech Hunter | Biotech Hunter